Suchergebnisse - "Cook, Gordon"

PubPharm (2)

1

Response-adapted intensification with cyclophosphamide, bortezomib, and dexamethasone versus no intensification in patients with newly diagnosed multiple myeloma (Myeloma XI) : a multicentre, open-label, randomised, phase 3 trial

enthalten in: The Lancet. Haematology | 2019

von Jackson, G. | Davies, F. | Pawlyn, C. | +20

2

The effect of salvage autologous stem-cell transplantation on overall survival in patients with relapsed multiple myeloma (final results from BSBMT/UKMF Myeloma X Relapse [Intensive]) : a randomised, open-label, phase 3 trial

enthalten in: The Lancet. Haematology | 2016

von Cook, G. | Ashcroft, A. | Cairns, D. | +17

1
[1]